Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Change in Inventory (2018 - 2025)

Agios Pharmaceuticals' Change in Inventory history spans 7 years, with the latest figure at $886000.0 for Q4 2025.

  • For Q4 2025, Change in Inventory fell 25.36% year-over-year to $886000.0; the TTM value through Dec 2025 reached $5.3 million, down 37.89%, while the annual FY2025 figure was $5.3 million, 37.89% down from the prior year.
  • Change in Inventory reached $886000.0 in Q4 2025 per AGIO's latest filing, down from $1.2 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $4.3 million in Q2 2023 to a low of $867000.0 in Q2 2024.
  • Average Change in Inventory over 4 years is $2.1 million, with a median of $1.7 million recorded in 2023.
  • Peak YoY movement for Change in Inventory: soared 172.83% in 2023, then plummeted 79.82% in 2024.
  • A 4-year view of Change in Inventory shows it stood at $3.3 million in 2022, then crashed by 45.66% to $1.8 million in 2023, then plummeted by 34.13% to $1.2 million in 2024, then dropped by 25.36% to $886000.0 in 2025.
  • Per Business Quant, the three most recent readings for AGIO's Change in Inventory are $886000.0 (Q4 2025), $1.2 million (Q3 2025), and $1.2 million (Q2 2025).